Literature DB >> 20371550

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Menno Vergeer1, Adriaan G Holleboom, John J P Kastelein, Jan Albert Kuivenhoven.   

Abstract

There is unequivocal evidence of an inverse association between plasma high-density lipoprotein (HDL) cholesterol concentrations and the risk of cardiovascular disease, a finding that has led to the hypothesis that HDL protects from atherosclerosis. This review details the experimental evidence for this "HDL hypothesis". In vitro studies suggest that HDL has a wide range of anti-atherogenic properties but validation of these functions in humans is absent to date. A significant number of animal studies and clinical trials support an atheroprotective role for HDL; however, most of these findings were obtained in the context of marked changes in other plasma lipids. Finally, genetic studies in humans have not provided convincing evidence that HDL genes modulate cardiovascular risk. Thus, despite a wealth of information on this intriguing lipoprotein, future research remains essential to prove the HDL hypothesis correct.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371550      PMCID: PMC2903818          DOI: 10.1194/jlr.R001610

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  206 in total

1.  High-density lipoprotein restores endothelial function in hypercholesterolemic men.

Authors:  Lukas E Spieker; Isabella Sudano; David Hürlimann; Peter G Lerch; Markus G Lang; Christian Binggeli; Roberto Corti; Frank Ruschitzka; Thomas F Lüscher; Georg Noll
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

2.  Characterization of the lipolytic activity of endothelial lipase.

Authors:  Mary G McCoy; Gwo-Shing Sun; Dawn Marchadier; Cyrille Maugeais; Jane M Glick; Daniel J Rader
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

3.  Synthetic LXR ligand inhibits the development of atherosclerosis in mice.

Authors:  Sean B Joseph; Elaine McKilligin; Liming Pei; Michael A Watson; Alan R Collins; Bryan A Laffitte; Mingyi Chen; Grace Noh; Joanne Goodman; Graham N Hagger; Jonathan Tran; Tim K Tippin; Xuping Wang; Aldons J Lusis; Willa A Hsueh; Ronald E Law; Jon L Collins; Timothy M Willson; Peter Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study.

Authors:  Greetje J de Grooth; Jan Albert Kuivenhoven; Anton F H Stalenhoef; Jacqueline de Graaf; Aeilko H Zwinderman; Jan L Posma; Arie van Tol; John J P Kastelein
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

5.  Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.

Authors:  Ann Mertens; Peter Verhamme; John K Bielicki; Michael C Phillips; Rozenn Quarck; Wim Verreth; Dominique Stengel; Ewa Ninio; Mohamad Navab; Bharti Mackness; Mike Mackness; Paul Holvoet
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

6.  Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.

Authors:  Robert J Aiello; Dominique Brees; Patricia-Ann Bourassa; Lori Royer; Saralyn Lindsey; Timothy Coskran; Mehrdad Haghpassand; Omar L Francone
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

7.  HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells.

Authors:  Fanny Robbesyn; Virginie Garcia; Nathalie Auge; Otilia Vieira; Marie-Françoise Frisach; Robert Salvayre; Anne Negre-Salvayre
Journal:  FASEB J       Date:  2003-02-05       Impact factor: 5.191

8.  Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.

Authors:  Miranda van Eck; I Sophie T Bos; Wolfgang E Kaminski; Evelyn Orsó; Gregor Rothe; Jaap Twisk; Alfred Böttcher; Edwin S Van Amersfoort; Trudy A Christiansen-Weber; Wai-Ping Fung-Leung; Theo J C Van Berkel; Gerd Schmitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

9.  Increased ABCA1 activity protects against atherosclerosis.

Authors:  Roshni R Singaraja; Catherine Fievet; Graciela Castro; Erick R James; Nathalie Hennuyer; Susanne M Clee; Nagat Bissada; Jonathan C Choy; Jean-Charles Fruchart; Bruce M McManus; Bart Staels; Michael R Hayden
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  54 in total

Review 1.  Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.

Authors:  K Mahdy Ali; A Wonnerth; K Huber; J Wojta
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 3.  Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights.

Authors:  Ricardo Stein; Filipe Ferrari; Fernando Scolari
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

Review 4.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

5.  Exercise Training at Maximal Fat Oxidation Intensity for Overweight or Obese Older Women: A Randomized Study.

Authors:  Liquan Cao; Yan Jiang; Qingwen Li; Jianxiong Wang; Sijie Tan
Journal:  J Sports Sci Med       Date:  2019-08-01       Impact factor: 2.988

6.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

7.  Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol.

Authors:  Brian H Shirts; Michael T Howard; Sandra J Hasstedt; M Nazeem Nanjee; Stacey Knight; John F Carlquist; Jeffrey L Anderson; Paul N Hopkins; Steven C Hunt
Journal:  Atherosclerosis       Date:  2012-03-01       Impact factor: 5.162

8.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

Review 9.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

Review 10.  Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?

Authors:  Baohai Shao; Jay W Heinecke
Journal:  Expert Rev Proteomics       Date:  2017-11-13       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.